PCNL Versus RIRS for Management of Stones in Solitary Kidney
Percutaneous Nephrolithotomy Versus Retrograde Intrarenal Surgery for Management of Stones in Solitary Kidney: Assessment of Outcomes and Complications Through a Prospective Non Randomized Trial
1 other identifier
interventional
83
1 country
1
Brief Summary
Few studies compared PCNL and RIRS for stones in solitary kidney. Current guidelines do not provide clear recommendations concerning the management of renal stones in patients with solitary kidney. The study aims to compare the safety and efficacy of the use of percutaneous nephrolithotomy (PCNL) and flexible ureteroscopy in the treatment of renal stones \_ ≤ 3 cm in largest diameter through a prospective non randomized study in the period between August 2024 and August 2026. Stone-free rate will be assessed by NCCT done at 1st day postoperative and after 3 months. For Evaluation of kidney function postoperatively, creatinine clearance will be done after 1month and renal isotope scan will be done after 3 months. In addition, the results will be compared to the data of the patients with solitary kidney and renal stones who were retrospectively treated by PCNL or RIRS in the period between 2002 and 2024. The cases should fulfil the same inclusion criteria of the prospective study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 23, 2024
CompletedFirst Submitted
Initial submission to the registry
July 5, 2026
CompletedFirst Posted
Study publicly available on registry
July 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedJuly 28, 2026
July 1, 2026
1.7 years
July 5, 2026
July 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
stone free rate
Stone-free status: it will be assessed by NCCT (defined as the absence of any stones or presence of only clinically insignificant residual stones \< 4 mm as measured by NCCT). Sub classified to * Initial stone free rate (1st day postoperative) * Final stone free rate (after 3 months)
within 3 months after surgery
Secondary Outcomes (7)
complication rate
within 30 days after surgery
number of sessions
3 months after surgery
renal function evaluation
within 3 months after surgery
auxiliary procedures
within 3 months after surgery
hospital stay
from date of surgery until hospital discharge ( up to 30 days )
- +2 more secondary outcomes
Study Arms (2)
RIRS
EXPERIMENTALpatients undergo retrograde intrarenal surgery (RIRS) for management of stones in solitary kidney
PCNL
EXPERIMENTALpatients undergo percutaneous nephrolithotomy (PCNL) for management of stones in solitary kidney
Interventions
standard retrograde intrarenal surgery (RIRS) for management of stones in solitary kidney
standard percutaneous nephrolithotomy (PCNL) for management of stones in solitary kidney
Eligibility Criteria
You may qualify if:
- Patients with anatomical or functional solitary kidney.
- Renal stones ≤ 3 cm in largest diameter- as measured by non-contrast spiral CT
- Age ≥ 18 years.
You may not qualify if:
- Patients who did not meet the above criteria.
- bleeding diathesis or those on anticoagulant therapy.
- concomitant pathology as ureteric stricture or renal congenital anomalies .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Urology and Nephrology center , Mansoura University
Al Mansurah, Dakahlia Governorate, 35516, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed M. Shoma, Professor of urology
Urology and Nephrology Center , Mansoura university , Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2026
First Posted
July 28, 2026
Study Start
November 23, 2024
Primary Completion
August 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
July 28, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share